Dyne Therapeutics DYN
NASDAQ DYN
$15.62 -0.15 (-0.95%)
At close: Oct 23, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Sale and Maturity of Investments (2021 - 2026)

Updated

Analysis

Dyne Therapeutics (DYN) Sale and Maturity of Investments (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Dyne Therapeutics 2.59 Bn -1.19 Bn - 39.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.51 Mn
Mar 31, 2026 62.11 Mn
Dec 31, 2025 28.18 Mn
Sep 30, 2025 28.14 Mn
Jun 30, 2025 47.77 Mn
Mar 31, 2025 68.41 Mn
Dec 31, 2024 37.78 Mn
Sep 30, 2024 37.89 Mn
Jun 30, 2024 38.34 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 26.28 Mn
Sep 30, 2023 22.57 Mn
Jun 30, 2023 35.48 Mn
Mar 31, 2023 43.98 Mn
Dec 31, 2022 46.22 Mn
Sep 30, 2022 57.73 Mn
Jun 30, 2022 52.91 Mn
Mar 31, 2022 54.59 Mn
Dec 31, 2021 30.27 Mn
Sep 30, 2021 49.68 Mn
API Access

Dyne Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=DYN&period=max&api_key=YOUR_API_KEY